Stockreport

Boston Scientific: Reclaiming Neurovascular Dominance Through Thrombectomy Precision [Seeking Alpha]

Boston Scientific Corporation  (BSX) 
Last boston scientific corporation earnings: 4/29 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.bostonscientific.com
PDF BSX expands into high-growth neurovascular and peripheral thrombectomy segments, leveraging PEN's 11% WAMGR pipeline and robust product suite. The acquisition is expe [Read more]